Lara E Davis

18PUBLICATIONS
132CO-AUTHORS
Biologically active moleculesMolecular targetsOral and maxillofacial surgerySolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 08, 2026
RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Finding Clinical Trial.

|Jun 18, 2026
Comprehensive Multi-Omic Profiling of Desmoplastic Small Round Cell Tumors Identifies Targetable Pathways with Therapeutic Opportunities.

|Apr 29, 2026
YB-1 Inhibition Suppresses Osteosarcoma Growth and Reverses Tumor Immunosuppression.

|Feb 20, 2026
Consensus recommendations in the management of jaw (gnathic) osteosarcoma.

Matthew S Dietz, Lara E Davis, Pinki K Prasad

|Jan 02, 2026
Considerations for Clinical Trial Design in Relapsed and Refractory Osteosarcoma: An FDA Symposium.

Kristin M Wessel, Katherine A Janeway, Lara E Davis

|Sep 08, 2025
Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma.

Michelle Choe, Danielle Kirkey, Isabel Lira

Pageof 3

Frequent Collaborators

2 joint publications

Florence Choo

2 joint publications

Sanjay V Malhotra

2 joint publications

Monika Davare

2 joint publications

Brian A Van Tine